Alliance Pharma Targeting M&A To Grow OTC Portfolio
Executive Summary
UK-based Alliance Pharma is currently looking at deals - large and small - to expand its consumer health portfolio in its existing markets, including the US and Europe.
You may also be interested in...
Alliance Pharma Grows In US With Amberen Menopause Supplement
UK-based Alliance Pharma has strengthened its US offering by acquiring Biogix and its Amberen menopause supplement.
European OTC Results Round-Up: Boiron, Alliance Pharma and Karo
COVID-19 had a differing impact on Q2 consumer health sales for France's Boiron, the UK's Alliance Pharma and Sweden's Karo.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.